Publication | Open Access
Phase I and II trials of subcutaneously administered rIL-2, interferon alfa-2a, and fluorouracil in patients with metastatic renal carcinoma
16
Citations
0
References
2001
Year
UrologyGenitourinary CancerMedicinePharmacologyMetastatic Renal CarcinomaPharmacotherapyAnti-cancer AgentCancer TreatmentIi TrialsOncology
No additional data available for this publication yet. Check back later!